Search Results for: hepatitis C

February 16, 2017February 16, 2017

Cirrhosis Increasing Among Hepatitis C Patients, According to Large US Study

Hepatitis C, News

The past decade has seen a nearly 40 percent increase in the prevalence of cirrhosis among people with hepatitis C in the U.S., a new study found. The reasons remain ... Read more

February 7, 2017February 7, 2017

Hepatitis C Therapy Candidate Granted Priority Review from Health Canada

Hepatitis C, News

A potential new drug being developed for the treatment of chronic hepatitis C received priority review from Health Canada. This means that the compound may be reviewed in advance of ... Read more

January 31, 2017January 31, 2017

Hepatitis C Virus Associated with Multiple Cancers, Study Finds

Hepatitis C, News

The hepatitis C virus (HVC) had been linked previously to increased risk of a certain liver cancer and subtypes of non-Hodgkin lymphoma. Now a new study that examined more than ... Read more

January 12, 2017January 12, 2017

AbbVie’s One-Pill Combo Therapy Shows Promise for Hepatitis C in Japanese Trial

Hepatitis C, News

AbbVie’s new hepatitis C treatment candidate, a one tablet combination of the investigational drugs glecaprevir and pibrentasvir, harnessed the infection in all patients who completed a Japanese study. The treatment, ... Read more

January 10, 2017January 10, 2017

Blacks, Hispanics with Hepatitis C More Likely to Fail Treatment with Direct-Acting Antiviral Agents

Hepatitis C, News

Within the U.S. Veterans Affairs’ healthcare system, black and Hispanic patients with hepatitis C are more likely to fail treatment with direct-acting antiviral (DAAs) drugs, than patients who are white, a ... Read more

December 20, 2016December 20, 2016

Hepatitis C Therapy Sovaldi Can Adversely Interact with HIV Therapy Viread, Study Says

Hepatitis C, News

The hepatitis C drug Sovaldi (sofosbuvir) can adversely interact with the human immunodeficiency virus (HIV) drug Viread (tenofovir disoproxil), according to recent findings. Both drugs are manufactured and commercialized by Gilead ... Read more

November 29, 2016November 29, 2016

Gilead Sciences Canada Recognized for Developing Harvoni as Hepatitis C Therapy

Hepatitis C, News

Gilead Sciences Canada has been awarded this year’s Prix Galien Canada–Innovative Product Award for the development of Harvoni (ledipasvir/sofosbuvir), a once-daily combination pill for the treatment of chronic genotype 1 hepatitis ... Read more

November 22, 2016November 22, 2016

Research Discovery May Explain Why Interferon-Induced Therapies Fail for Hepatitis C Patients

Hepatitis C, News

Researchers at the University of Washington have discovered that the virus that causes hepatitis C is capable of manipulating infected liver cells from the host, blocking signaling pathways that can trigger ... Read more

November 8, 2016November 8, 2016

Promising Phase 1 Data Reported for Chronic Hepatitis C Investigational Therapy

Hepatitis C, News

Phase 1 clinical trial results show that CoCrystal Pharma’s CC-31244, a potential new therapy for hepatitis C virus (HCV) infections, meets the criteria to qualify for further testing. The randomized, ... Read more

October 25, 2016October 25, 2016

Combo Anti-Viral Treatment for Chronic Hepatitis C Shows Efficacy in Phase 3 Studies

Hepatitis C, News

Top-line results from four global Phase 3 clinical studies (POLARIS-1, POLARIS-2, POLARIS-3, and POLARIS-4), led by Gilead Sciences, showed that the combination of sofosbuvir/velpatasvir/voxilaprevir (SOF/VEL/VOX) — inhibitors of viral activity — can ... Read more